Skip to Content

Bhang Inc Sub Voting BHNGF

Morningstar Rating
$0.00 0.00 (99.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BHNGF is trading at a 52% discount.
Price
$0.00
Fair Value
$8.73
Uncertainty
Extreme
1-Star Price
$1.57
5-Star Price
$5.59
Economic Moat
Wjn
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BHNGF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.02
Bid/Ask
$0.01 / $0.02
Market Cap
$234.76
Volume/Avg
27,354 / 16,923

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Bhang Inc produces and distributes cannabis-infused products that are distributed worldwide. It provides a portfolio of over 100 cannabis, hemp-derived cannabidiol (CBD), and terpene products. The firm's products include chocolate, gum, capsules, CBD gummies, E-liquid, beet shots, tinctures, pre-roll straights, spray, and CBD crystalline isolate, among others. The company's geographical segments are Canada and United States.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees

Valuation

Metric
BHNGF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
BHNGF

Financial Strength

Metric
BHNGF
Quick Ratio
0.27
Current Ratio
0.42
Interest Coverage
−69.81
Quick Ratio
BHNGF

Profitability

Metric
BHNGF
Return on Assets (Normalized)
−156.28%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
BHNGF
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRBbldjwyfmgTzxpwft$71.2 Bil
ZTS
Zoetis Inc Class AHcsklfvgmQqk$68.3 Bil
HLN
Haleon PLC ADRTpphvtzvKwq$37.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRKnvldjxXrm$14.5 Bil
VTRS
Viatris IncFrqvkcmcTxrq$13.4 Bil
RDY
Dr Reddy's Laboratories Ltd ADRHxmgfdnTqcn$11.9 Bil
CTLT
Catalent IncSgxbbpdQtyscw$10.1 Bil
PRGO
Perrigo Co PLCXhqvwgrzQsbqr$4.1 Bil
CURLF
Curaleaf Holdings IncFrqfvhrjqPjwjf$3.6 Bil
PBH
Prestige Consumer Healthcare IncJxnldzlXgzjr$3.5 Bil

Sponsor Center